What Can You Expect in 2025?

With 400+ active radiopharmaceuticals drugs currently in development and expanding into new disease indications, this year’s 4th Targeted Radiopharmaceuticals Summit US is designed to evolve with you, returning with a refreshed and comprehensive program, covering the latest industry developments and addressing pressing challenges.

Offering a unique opportunity for you to join the dedicated TRP community at a niche and intimate forum addressing TRP industry-specific topics, all to advanced candidates to approval and commercialization. Key areas of focus include isotope supply, clinical development, regulatory clarity, novel molecule design, and much much more.

TRP Networking Image

Unmissable Agenda Highlights

Harnessing Cutting-Edge Engineering Techniques

Pioneering novel radiopharmaceutical targeting molecules derived from engineered antibodies, peptides, bi-specifics and mini proteins with Telix Pharmaceuticals, AI Proteins, OncoOne and VitsGen

Ensuring Successful Clinical Translation

Employing phase zero and optimal first-in human design strategies with AdvanCell, Alpha-9 Oncology and RayzeBio, while leveraging real-world evidence in late-phase design with UCLA, UCSF and Convergent Tx

Evaluating the Supply Chain and CMC Landscape

Analyzing the current and future dynamics of radiopharmaceutical supply chains, and the CMC landscape, including isotope availability, funding trends, and emerging technologies with William Blair and Abdera Therapeutics

Understanding the Radiopharmaceutical Regulatory Landscape

Comparing diagnostics, theranostics and therapeutics, while harmonizing regulatory standards with RadioPharm Theranostics and Fusion Pharmaceuticals

Attracting Continued Investment and Funding

Understanding investor trends, focusing on, targeting moiety, platform technology, and payloads with Novartis, William Blair, Telix Pharmaceuticals, and Alpha-9 Oncology

Divide & Conquer

Built with input from experts at Novartis, Eli Lilly, Telix Pharmaceuticals, and many others, the program has been specifically designed to address the key challenges at each stage of development. The summit will also bring everything together with broader topics covered in our plenary session, catering to the entire audience.

A snapshot of key sessions featured in each track across the 2025 program:

Discovery & Preclinical Track

Expanding Horizons with Novel Targeting Moieties to Optimize Radiopharmaceutical Development

• Alessandro Mascioni, Director, Targeting Technologies, Telix Pharmaceuticals
• James Bowman, Director of Protein Engineering, AI Proteins

Translational & Early Stage Clinical Track

Delivering Translational Success Through Optimal Preclinical Insights & Forward-Thinking Radiopharmaceutical Design

• Micheal Groaning, Vice President, Global Program Leader, Fusion Pharmaceuticals
• Amreen Husain, Chief Medical Officer, RayzeBio

Supply Chain & Late Stage Clinical Track

Strengthening Radiopharmaceutical CMC & Supply Chain through Novel Technologies & Regulatory Understandings While Streamlining Commercialization

• Kevin Roland, Vice President, CMC, Abdera Therapeutics
• Johannes Czernin, Professor, UCLA

Explore the Full Event Guide

  • 50+ World-Class TRP Speakers
  • 3 Days of Exclusive, Data-Driven TRP Content
  • Unmatched Networking & Strategic Partnering Opportunities
  • Focused Industry-Led Community of Top Radiopharmaceutical Biopharma
brochure cover - 4th TRP Summit

Attending Companies Include

48hour Discovery Logo
Abdera Therapeutics Logo
AdvanCell - 4th TRP US
aixial group - 4th TRP US
aktis oncology - 4th TRP US
almac - 4th TRP US
Alpha-9 Oncology Logo
archon bio - 4th TRP US
AstraZeneca_logo - 4th TRP US
Atomvie Logo
bayer - 4th TRP US
BIOLOGIC Logo
Bivision Pharmaceuticals, Inc- 4th TRP US
brfla - 4th TRP US
Bristol Myers Squibb - 4th TRP US
BWXT Medical Ltd. - 4th TRP US
centre_for_probe_development_and_commercialization_logo - 4th TRP US
cm resources- 4th TRP US
Comecer Spa - 4th TRP US
Convergent Therapeutics, Inc - 4th TRP US
Curium Pharma North American - 4th TRP US
Eli_Lilly_and_Company - 4th TRP US
Flywheel Logo
ionetix Logo
Isotopia Molecular Imaging Logo
ITM Logo
Mariana Oncology Logo
Modular Devices Logo
NorthStar Medical Radioisotopes Logo
Novartis AG Logo
PepLib Logo
Peptifinder Logo
Perceptive Logo
PharmaLogic Logo
PSI CRO Logo
Ratio Therapeutics Logo
RayzBio Logo
Stream Logo
TD2-Oncology - partner - 4th TRP Summit
Terthera Logo
Thermofisher Logo
Trasis Logo
UCLA Logo
VitsGen Logo
TRP Conference Image
Explore the Agenda

Hear the latest industry-led breakthroughs and gain exclusive insights on radiopharmaceutical innovations during our packed agenda, interactive roundtables, and panel discussions.

TRP Conference Image
Partner With Us

As the field rapidly expands, position yourself alongside leading solution providers to ensure your brand stands out as a premier choice amid growing competition.

TRP Conference Image
Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.